ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,058Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 103

$557K Total Retail Price of All Prescriptions

Rank: 32 out of 103

332 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,007 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 489 445 1 1
OMEPRAZOLE 423 348 2 3
WARFARIN SODIUM 333 231 3 7
LISINOPRIL 327 261 4 5
FUROSEMIDE 307 255 5 4
AMLODIPINE BESYLATE 296 251 6 6
METOPROLOL SUCCINATE 259 197 7 8
POTASSIUM CHLORIDE 223 165 8 10
PRAVASTATIN SODIUM 201 163 9 33
HYDROCODONE-ACETAMINOPHEN 199 170 S3 10 11
SIMVASTATIN 187 158 11 2
LOSARTAN POTASSIUM 180 157 12 12
METOPROLOL TARTRATE 164 135 13 9
CITALOPRAM HBR 153 135 14 15
METFORMIN HCL 125 100 15 13
ZOLPIDEM TARTRATE 123 105 16 29
CYCLOBENZAPRINE HCL 106 23 R 17 83
TAMSULOSIN HCL 106 94 17 23
ATORVASTATIN CALCIUM 103 87 19 18
SERTRALINE HCL 99 62 20 21
ALENDRONATE SODIUM 97 86 21 19
DONEPEZIL HCL 87 87 22 28
KLOR-CON 10 87 68 22 45
TRAMADOL HCL 86 74 24 17
CARVEDILOL 86 64 24 20
PREDNISONE 82 53 26 24
SYNTHROID 81 50 27 51
MIRTAZAPINE 77 77 28 36
ZETIA 73 64 29 66
DIGOXIN 71 50 30 25
NEXIUM 70 42 31 43
ADVAIR DISKUS 68 59 32 42
LEVOFLOXACIN 65 52 33 57
ALLOPURINOL 65 58 33 26
BENAZEPRIL HCL 63 63 35 93
DIOVAN 60 60 36 40
TRIAMCINOLONE ACETONIDE 60 57 36 107
GABAPENTIN 60 50 36 22
CYMBALTA 59 14 39 60
FENOFIBRATE 59 47 39 58
BACLOFEN 59 38 39 150
KLOR-CON M20 58 48 42 56
AZITHROMYCIN 56 50 43 44
CLONIDINE HCL 54 54 44 82
PLAVIX 54 46 44 46
BUTORPHANOL TARTRATE 53 53 46 228
TRANDOLAPRIL 52 42 47 234
CLOPIDOGREL 52 42 47 32
AMITIZA 51 28 49 237
NAMENDA 50 50 50 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.